Acute Coronary Syndromes in Semi-Urban African Areas: Clinical Aspects and Management in Ziguinchor (Senegal) ()
1. Introduction
Cardiovascular disease remains today the main cause of death in Western countries and the second cause of death in France behind cancer. According to the World Health Organization (WHO), 17.5 million deaths were attributable to cardiovascular disease worldwide in 2015, or 31% of all deaths, including 7.4 million from coronary heart disease alone (13% of the global total mortality) [1]. Acute coronary syndrome (ACS) consists of the clinical, electrocardiographic and laboratory manifestations associated with coronary atherosclerosis. ACS is a real public health problem. In Europe and the United States, the prevalence of coronary artery disease is changing and the rates vary, depending on the country, from 43 to 144/100,000 inhabitants per year. Worldwide, the frequency of ischemic heart disease (IHD) is increasing and is the most common cause of death [2].
Acute Coronary Syndromes (ACS) have long been considered less common in sub-Saharan Africa. However, for several years, we have observed their constant increase due to the change in lifestyle, which tends to become westernized but also to diagnostic means, which are becoming more and more efficient, particularly in the urban area [3]. In sub-Saharan Africa, the consequences of this condition are serious because of insufficient prevention, pre-hospital care that remains exceptional, the long delay before hospitalization and the scarcity of adapted reception centers [4]. The World Health Organization estimated that in 2005 ischemic heart disease caused an estimated 361,000 deaths in the African region, and current projections suggest that number will almost double by 2030 [5].
Senegal is no exception, since more than half of patients admitted for ACS arrive after the twelfth hour [6] [7] [8] and pre-hospital care is almost non-existent outside the capital, Dakar. The city of Ziguinchor, which is located in the south of the country, has never been the subject of a study on ACS. We have therefore set ourselves the objectives of studying the epidemiological and clinical aspects and the acute coronary syndromes’ treatment.
2. Patients and Methods
This is a retrospective study carried out at the Emergency Reception Service of the Ziguinchor Peace Hospital and at the Cardiology Service of the Ziguinchor Regional Hospital Center concerning patients admitted for an acute coronary syndrome from January 1, 2016 to December 31, 2019.
We included in our study all patients of both sexes, presenting acute angina pain at rest and/or electrocardiographic changes in at least 2 contiguous leads of elevation or under shift type significant of the ST segment or the negative or positive T waves, sharp and symmetrical. We excluded patients with stable angina, chest pain and/or non-specific electrocardiographic changes, semi-recent or sequelae myocardial infarction and non-exploitable records.
The studied parameters were prevalence, age, sex, geographic origin, cardiovascular risk factors, clinical and paraclinical aspects (Electrocardiogram, biology, and Doppler echocardiography), time to treatment, therapeutic modalities, intra-hospital course and prognosis.
We analyzed the statistical data using Sphinx V5 software. Chi-square test was used and was considered significant for a p value < 0.05.
We made sure that the confidentiality of participants’ study was ensured by using personal identification numbers on data collection forms instead of names. Personal identifiers will not be included in study reports. All study records are confidential.
3. Results
During the period of our study, 1342 patients had been admitted to our study sites for a cardiovascular disease, including 75 for an acute coronary syndrome corresponding to a hospital prevalence of 5.6%. Only the 57 patients’ records had been retained, of which 40 admitted for an ACS with persistent ST segment elevation and 17 admitted for an ACS without ST segment elevation.
The male sex predominated with 45 men (78.9%) and 12 women (21.1%), for a sex ratio of 3.7.
The average age of the patients was 60.1 ± 14.1 years with extremes of 31 and 90 years. The peak was in the 61 to 70 age group (28.1%). An ACS of the young subject was noted in 4 patients (7%) with an age of less than 40 years. For men, the average age was 59.8 years and 61.1 years for women.
The majority of patients (65.4%) were from the city of Ziguinchor, 30.9% from surrounding villages and 3.6% from Guinea Bissau.
The cardiovascular risk factors are summarized in Table 1.
The diabetics were all type II. Smoking was active for all patients who were exclusively male. The number of pack-years averaged 30.6 with extremes of 2 and 80.
The average cardiovascular risk factor index was 1.9. The majority of patients (59.6%) were multifactorial. Only one patient had no risk factors found.
Table 1. Cardiovascular risk factors.
CVRF: Cardiovascular risk factors; HBP: High Blood Pressure.
Typical angina pain (50.9%), dyspnea (43.9%), digestive signs (26.3%) and atypical chest pain (22.8%) dominated the reasons for consultations.
The abnormalities noted on the examination were left heart failure (21.1%), global heart failure (8.8%), cardiogenic shock (1.8%) and a heart sound deafness (21.1%).
The analysis of the electrocardiographic tracings made it possible to retain the diagnoses of ACS with persistent ST segment elevation in 40 patients (70.2%) and of ACS without ST segment elevation in 17 patients (29.8%). The anterior territory was the most represented (68.4%) followed by the lower territory (19.3%). An extension to the right ventricle was found in 4 patients (7%). The location of electrocardiographic abnormalities is summarized in Table 2.
Troponinemia was positive in all 7 patients in whom it was measured with an averge level of 3.5 ± 3.1 ng/l.
The admission blood glucose taken in 26 patients (45.6%) was upper to 1.24 g/l in 6 patients (23.1%) including 5 diabetics. It was on average 1.8 ± 1.2 g/l.
Cholesterol and triglyceride levels were measured in 33 patients (57.9%). Among them, 11 patients (33.3%) had total cholesterol levels above 2 g/l; 5 patients (15.2%) had HDL-cholesterol levels below 0.4 g/l, 13 patients (39.4%) had an LDL-cholesterol level upper to 1.3 g/l and 3 patients (9.1%) had a triglyceridemia superior to 1.5 g/l.
Biological renal failure was found in 17/49 patients (34.7%) and positive C Reactive protein (CRP) in 14/24 patients (58.3%).
The results of the biology are summarized in Table 3.
Table 2. Location of electrocardiographic abnormalities.
RV: right ventricle.
Table 3. Summary of biological parameters.
The Doppler echocardiography performed in 43 patients (75.4%) found segmental kinetics abnormalities in 69.8% of patients with a predominance of hypokinesia (58.1%) and most often affected the septal wall (60.5%), an impaired left ventricular systolic function in 51.2% of patients with an average left ventricular systolic ejection fraction of 52.4% ± 16.1% (extreme 18% and 77%). It also found a left ventricular dilation in 34.9% of patients and moderate abundant pericardial effusion in one patient. The average time to treatment was 3.4 ± 4.5 days. 13 patients were seen before 12 hours after the onset of symptoms.
Therapeutically, no patient had undergone thrombolysis. The used drugs are summarized in Table 4.
After an average hospitalization of 5 days ± 3.2, the development in a hospital environment was favorable in 43.6% of cases. Complications occurred in 56.4% of the patients.
The hospital lethality of ACS was 7.2%.
Multivariate analysis was performed for prognostic factors.
We investigated the influence of various factors on the prognosis using the presence of a complication and death as the combined criteria.
The Fisher test used was considered significant for a p value < 0.05.
On the list of variables tested, two are linked to the development variable (favorable vs. death/complication) in bivariate mode. Indeed, the Fisher tests above between the explanatory variables and the dependent development variable show that at the 5% level, we cannot reject the null hypothesis of independence for any variable except the number of risk factors superior to 2 (p = 0.026) and the treatment length upper to 12 hours (p = 0.000). Then, multivariate analysis was performed to test all variables simultaneously. A logistics model with a Stepwise approach carried out using the Stata software gave the following results.
At the significance level of 5%, the variables glycemia on admission superior to 1.24 g/L, treatment length upper to 12 hours and left ventricular ejection fraction less than 50% are linked to the evolution of the assumption of responsibility. An admission glycemia superior to 1.24 g/L (OR = 6.19 [1.21 - 31.72]), a recovery period of more than 12 hours (OR = 4.99 [1.25 - 19.92]) and a left ventricular ejection fraction of less than 50% (OR = 5.94 [1.30 - 27.01]) are associated with a risk of death and/or complications.
Table 4. Summary of the main used drugs.
4. Discussion
In Africa, there is a steady increase in the prevalence of ischemic heart disease. Indeed, it went from 4.05% in 2006 [7] to 13.5% in 2013 [6]. The constant increase in the prevalence of ACS in Africa could be explained on the one hand by the modification of the populations’ lifestyle and on the other hand, by the increase of human and material resources favoring the diagnosis. In our work, the hospital prevalence of ACS was 5.6%.
The sex ratio in our study is 3.7 in favor of men. This is corroborated by data from the literature [7] [8] [9]. However, this predominance tends to decrease with age, which could be explained by the gradual decline in estrogen during pre-menopause [10].
The average age of our patients was 60.1 ± 14.1 years. Khalfallah [11] and Mboup [7] were respectively 55.5 years old in Tunisia and 57.1 years old in Dakar. In the European and North American series, the average age of onset of ACS was higher. He was 67 and 62.6 years old respectively in France [12] and Canada [13]. This disparity could be explained by the much higher life expectancy in developed countries and the early cardiovascular risk factors’ treatment in these countries.
The most common cardiovascular risk factors found in our study were high blood pressure, high cholesterol, diabetes, active smoking, obesity and physical inactivity. This observation was noted in the INTERHEART Africa study [14] where these risk factors were implicated in 89.2% of the first episodes of myocardial infarction in sub-Saharan Africa. The increasing magnitude of these cardiovascular risk factors in our regions explains the increased incidence of coronary heart disease.
Typical anginal pain dominated the functional symptomatology of our patients as reported in the literature [6] [7] [15]. We found digestive signs in 26.3% of cases, which underlines the importance of the ECG in this context.
The distribution of clinical ACS forms in our study is superimposable on certain data described in the African literature [15] [16]. The preponderance of the anterior territory involvement (68.4%) in our study confirms a well-established fact in previous studies [4] [15] [16].
Seck [4] as well as Mboup [7] had measured troponinemia in 96% and 81.3% of patients, respectively, in 2006 in Dakar. This reflects a better integration of this biological parameter in the diagnostic process of painful thoracic syndromes at the emergency reception services of Dakar hospitals. In our work, it was measured in 12.3% of patients. This is linked to the inadequacy of the technical platform in the city of Ziguinchor. Equipping peripheral medical structures with means for early diagnosis of ACS (ECG, troponin assay) would greatly contribute to improving the diagnosis of ACS and their treatment.
In our study, individualized systolic left ventricular dysfunction in 51.2% of patients was a factor of poor prognosis in multivariate analysis as highlighted by Cambou in the USIK study where it was found in 54% of patients [12]. The treatment was medical in all our patients and consisted of the administration of a double antiplatelet aggregation, an anti-coagulation with a low molecular weight heparin. ACE inhibitors, beta blockers and statins were administered in 84.2%, 57.9% and 82.5% of patients, respectively.
No patient had benefited from thrombolysis in our study because the treatment times were long and the thrombolytic was not available in most cases, whereas 13 patients (22.8%) had been received before the twelfth hour and could have benefited from thrombolysis. The mortality rate in our study, of 7.2%, is lower than that of Thiam in 2000 (10%) [8] and Mboup in 2006 (15.25%) [7]. This could presage a transition to lower mortality in our country.
The following factors in our study were risk factors for complications and/or hospital death: a cardiovascular risk factor number superior to 2 (p = 0.026), admission blood glucose upper to 1.24 g/l (OR = 6.19 [1.21 - 31.72]), a left ventricular ejection fraction less than 50% (OR = 5.93 [1.30 - 27.01]), a charge superior to 12 h (p = 0.000; OR = 4.99 [1.24 - 19.92]). Age was not a factor of poor prognosis in our study, unlike the results of De Matos Soeiro in which, in patients with acute coronary syndromes, age was an important predictor of mortality and complications [17].
The limits of this study are those inherent in any retrospective study, in particular the lack of numerous clinical and paraclinical data.
5. Conclusion
ACS is a major medical emergency due to their complications and the mortality they cause in our regions. However, diagnostic and therapeutic means are lacking in a city like Ziguinchor, hence the importance of properly identifying and controlling the risk factors for atherosclerosis.
Authors’ Contribution
All the authors contributed to the conduct of this work. All authors have read and approved the latest version of this manuscript.